Siddhartha C. Kadia is a renowned leader in global executive management and public company governance. Currently serving on the boards of ALS Limited and Applied Technical Services, he has excelled in Life Sciences tools, Diagnostics, Genomics, Medical Devices, High Tech, and TIC industries.
As the former President and CEO of PhenomeX and EAG Laboratories, he played a pivotal role in the latter's acquisition by Eurofins Scientific. With extensive experience at Life Technologies and McKinsey & Company, Siddhartha brings a multidisciplinary, international perspective.
His governance roles extend to public companies like NuVasive, Horizon Discovery Group, and Newport Corporation. As an investor and board member of private companies such as Isoplexis, Bioskryb Genomics, and SeQureDx, he contributes to their early-stage growth.
Academically accomplished with a PhD in Biomedical Engineering from Johns Hopkins University, Siddhartha is actively involved with global academic centres. Beyond his professional achievements, he resides in Solana Beach, California, with a deep passion for science, humanities, and arts, embodying a career dedicated to advancing technology and life sciences worldwide.